American Diabetes Association
Browse

Arterial Stiffness is Related to Diabetes-Associated Microvascular Complications: the SEARCH for Diabetes in Youth Study

figure
posted on 2025-02-14, 15:13 authored by Ryan P Brady, Elaine M Urbina, Zhiqian Gao, Dana Dabelea, Eva Lustigova, Santica Marcovina, Amy K Mottl, Catherine Pihoker, Kristi Reynolds, LeAnne Sancrainte, Lawrence M Dolan, Amy S Shah

Objective: To assess the relationship between arterial stiffness, an early marker of macrovascular cardiovascular disease, and microvascular complications in adolescents and young adults with youth-onset diabetes. Research Design and Methods: This study included 1226 individuals (median age initial visit 18 years, 58% female, 53% Non-Hispanic White, 22% Non-Hispanic Black, 20% Hispanic) with youth-onset type 1 or type 2 diabetes from the SEARCH for Diabetes in Youth Study. Arterial stiffness measures included pulse wave velocity for carotid-femoral (PWVcf), carotid-radial (PWVcr), femoral-foot (PWVff) and augmentation index (AIx). Microvascular complications included microalbuminuria, peripheral neuropathy, and retinopathy. Participants were followed up once at approximately 5 years. Results: Cross-sectionally, in type 1 diabetes, AIx was associated with higher odds of having any one microvascular complication (OR 1.35, 95% CI 1.04-1.76), microalbuminuria (OR 2.76, 95% CI 1.78-4.39), neuropathy (OR 1.63, 95% CI 1.07-2.50), and retinopathy (OR 1.37, 95% CI 1.06-1.79). In type 2 diabetes, AIx was associated with higher odds of microalbuminuria (OR 2.05, 95% CI 1.04-4.33), all p<0.05. In longitudinal analysis, in type 1 diabetes, a change in AIx was associated with the development of any one microvascular complication (OR 1.45, 95% CI 1.15-1.82), microalbuminuria (OR 5.42, 95% CI 1.98-14.80), neuropathy (OR 2.03, 95% CI 1.22-3.40), and retinopathy (OR 1.48, 95% CI 1.15-1.90). In type 2 diabetes, a change in AIx was associated with development of microalbuminuria (OR 21.98, 95% CI 1.30-372.88) (all p<0.05). Conclusions: Arterial stiffness is related to and predicts microvascular complications in youth-onset type 1 and type 2 diabetes.

Funding

Grant Support (SEARCH 4): The SEARCH for Diabetes in Youth Cohort Study (1R01DK127208-01, 1UC4DK108173) is funded by the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases and supported by the Centers for Disease Control and Prevention. The Population Based Registry of Diabetes in Youth Study (1U18DP006131, U18DP006133, U18DP006134, U18DP006136, U18DP006138, and U18DP006139) is funded by the Centers for Disease Control and Prevention (DP-15-002) and supported by the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Grant Support (SEARCH 1, 2, 3): SEARCH for Diabetes in Youth is funded by the Centers for Disease Control and Prevention (PA numbers 00097, DP-05-069, and DP-10-001) and supported by the National Institute of Diabetes and Digestive and Kidney Diseases. Kaiser Permanente Southern California (U48/CCU919219, U01 DP000246, and U18DP002714), University of Colorado Denver (U48/CCU819241-3, U01 DP000247, and U18DP000247-06A1), Cincinnati's Children's Hospital Medical Center (U48/CCU519239, U01 DP000248, and 1U18DP002709), University of North Carolina at Chapel Hill (U48/CCU419249, U01 DP000254, and U18DP002708), Seattle Children's Hospital (U58/CCU019235-4, U01 DP000244, and U18DP002710-01] and Wake Forest University School of Medicine (U48/CCU919219, U01 DP000250, and 200-2010-35171). ARK is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR002490. Funding was also provided by the T32 ES010957 Molecular Epidemiology in Children’s Environmental Health Training Program (MECEH) Grant Funding additionally provided by the Arnold W Strauss Award from Cincinnati Children’s Hospital Medical Center

History

Usage metrics

    Diabetes Care

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC